Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

T Monschein, S Dekany, T Zrzavy, M Ponleitner, P Altmann, G Bsteh, B Kornek, P Rommer, C Enzinger, F Di Pauli, Jörg Kraus (Co-author), T Berger, F Leutmezer, M Guger

Department of Labratory Medicine

Research output: Contribution to journal › Original Article › peer-review

2 Citations (Web of Science)

2 Citations
1 Correction

1 results

2023

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
Monschein, T., Dekany, S., Zrzavy, T., Ponleitner, M., Altmann, P., Bsteh, G., Kornek, B., Rommer, P., Enzinger, C., Di Pauli, F., Kraus, J. (Co-author), Berger, T., Leutmezer, F., Guger, M. & Austrian MS Treatment Registry AMSTR, Aug 2023, In: JOURNAL OF NEUROLOGY . 270, 8, p. 3787
Research output: Contribution to journal › Correction › peer-review

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

Research output

Search results

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)